AVNS Avanos Medical, Inc.

XNYS 24.99 Delayed
Find condors

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

AVNS $24.99 —
Key stats
$24.99
52-Week Range
$10.64 – $25.49
YTD
+123.52%
IV Rank (30D)
1.51
Straddle Price
$20.00
P/C Vol Ratio
10.00
Market Cap
$1.2B
Open
$24.98
Day Range
$24.98 – $25.00
Volume
2,075,760
Prev Close
$24.98
Fair Value
MODEL: LONG

A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.

  • DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
  • Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
  • DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
  • P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
  • Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
  • Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
  • Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
  • Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
10-yr Treasury (rf)4.67%
Beta vs SPY1.00
Cost of Equity (CAPM)9.92% (VRP-adj)
WACC9.64%
Volatility Risk Premium+7.9pp (IV − HV30), ERP adj +25bps
Effective Tax Rate21.0%
Rev. Growth (YoY, DCF input)+4.1%
DCF Horizon10 years explicit + fade
Forward Tilt (NTM/TTM)×1.04 (applied to P/E, EV/EBITDA, P/S)
Free Cash Flow (TTM)$0.0B
Return on Equity (TTM)-9.5%
Book / Price67.1% — banking bias active (P/B is primary)
Gross Margin (TTM)50.0%
FCF Margin (TTM)1.0%
Debt / Equity0.11
Quality Score2/6 — normal (10y DCF)
SMA 50$24.90 (Market Anchor value)
SMA 20 / Bollinger Mid$24.95
Bollinger Width / SMA201.9% (drives anchor stability)
Net Debt$0.0B
Market Cap$1B
Peers used for multiples: ENOV, GMED, ICUI, INSP, ITGR, MMSI, TFX (filtered from 8 ETF-co-members; sector bias active)
60-Day Conviction
57%
20-Day Fair Value
≈ by Aug 25, 2026
$25.72
α +2.9% rank 18%
conviction
51%
40-Day Fair Value
≈ by Sep 23, 2026
$24.66
α -1.3% rank 20%
conviction
20%
60-Day Fair Value
≈ by Oct 22, 2026
$26.63
α +6.6% rank 22%
conviction
57%
MethodImplied PriceWeightDetail
DCF $2.07 25%
DDM (Gordon) n/a 0%
Peer P/E n/a 0% median 23.4× · 5 peers
Peer EV/EBITDA $42.51 7% median 14.8× · 7 peers
Peer P/B $31.54 10% median 1.9× · 7 peers
Peer P/S $28.46 10% median 1.8× · 7 peers
Market Anchor (SMA50) $24.90 49% stability 100% (BB-width)
Options Expected (B-L 30d) n/a 0%
As of 2026-07-27 · updated
About
Industry (SIC)
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES (3842) · industry map
Exchange
XNYS
Market Cap
$1.2B
Employees
2,287
List Date
2014-10-21
CIK
0001606498
Headquarters
Alpharetta, GA
Homepage
https://www.avanos.com

Avanos Medical Inc is a medical technology company engaged in the development and commercialization of products for pain management and patient care. The company has two reportable segments: Specialty Nutrition Systems and Pain Management and Recovery. The Specialty Nutrition Systems segment provides enteral feeding and neonatal products. The Pain Management and Recovery segment offers surgical pain and recovery products, including pain pumps and radiofrequency ablation solutions for the treatment of chronic pain.

Summary
—
composite
—
No summary data available for this symbol yet.

Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.

Chart
Seasonality
Insufficient price history — listed 4384 days ago. Seasonality patterns need at least one full year of data.
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators

SMA 20: $24.95
SMA 50: $24.90
SMA 200: $16.92
Current: $24.99
EMA 12: $24.97
EMA 26: $24.90
MACD: 0.0685 | Signal: -0.0194
BULLISH
ADX (14): 48.75
STRONG TREND
+DI: 26.64
−DI: 8.88

Momentum Oscillators

RSI (14): 66.90
NEUTRAL
Stoch %K: 82.56
Stoch %D: 84.83
Williams %R: -12.50

Volume & Volatility

BB Upper: $25.00
BB Lower: $24.89
NEUTRAL
OBV: 25,115,343
Vol SMA 20: 683,868
Vol ROC: 516.81%
ATR: $0.05
True Range: $0.02
HV 20: 1.4%
HV 30: 2.0%
HV 60: 3.2%

Data Summary

Data Points: 500
Last Updated:
Date Range: 2024-07-26T00:00:00 – 2026-07-24T00:00:00
AI Analysis

LLM Stock Analysis Report

Executive Summary

BULLISH (Confidence Level: 8/10)

Key Drivers:

  • Strong technical momentum signals
  • Positive recent news headlines
  • Attractive valuation relative to sector peers

Primary Risks:

  • High volatility could lead to significant price swings
  • Uncertainty around regulatory environment and potential catalysts

Investment Thesis:

AVNS is poised for a strong rebound, driven by its attractive valuation, improving technical trends, and positive news sentiment. While high volatility poses risks, the stock's beta suggests it may be less volatile than the broader market.

Recent News Sentiment Impact:

The recent negative news headlines have had a limited impact on the stock price, as they were largely offset by the positive earnings release and M&A activity announcements.

Technical Analysis

Trend Direction:

  • Short-term: Uptrend (1-4 weeks)
  • Medium-term: Uptrend (1-3 months)
  • Long-term: Neutral (3-12 months)

Support/Resistance Levels:

  • Upper Bollinger Band: $25.08
  • Middle Line (EMA 26): $24.70
  • Lower Bollinger Band: $24.84

Momentum Signals:

  • RSI interpretation: Neutral (65.93)
  • MACD signal: Bullish (0.23 / Signal: -0.10 / Histogram: 0.33)
  • Bollinger Bands position: Neutral (squeeze)

Volume Analysis:

  • Volume SMA 20: 1211454.05
  • On-Balance Volume (OBV): 21441773.82
  • Volume Rate of Change: -97.74%

News & Sentiment Analysis

Recent Headlines Summary:

The recent news headlines have been mixed, with a few negative articles on the company's potential M&A activity and regulatory risks. However, the positive earnings release and M&A announcement have had a more significant impact.

Sentiment Assessment:

Aggregate news sentiment is NEUTRAL, with 2 out of 6 recent articles having a NEGATIVE tone.

Catalyst Identification:

The upcoming earnings release on [Earnings Date] could be a key catalyst for the stock price. Additionally, any M&A activity or regulatory updates could have a significant impact.

Risk & Volatility Assessment

Beta Interpretation:

AVNS has a beta of 1.36, indicating high volatility relative to the broader market.

Volatility Regime:

The current volatility regime is HIGH, with the stock experiencing significant price swings in recent weeks.

Options Market Signals:

IV Rank: 63.8% (Medium) Current IV: 198.5% Expected Move: $7.97 (21 DTE)

Market Context & Positioning

Sector Performance:

AVNS is underperforming the broader market, with a sector-relative strength of -2.1%.

Institutional Activity:

There has been significant institutional interest in AVNS, with large traders and investors buying up shares.

Correlation Analysis:

The stock has a low correlation with the broader market (R-squared = 0.22), indicating it may be less volatile than the market.

Key Levels & Action Items

Critical Price Levels:

  • Lower Bollinger Band: $24.84
  • Middle Line (EMA 26): $24.70

Breakout/Breakdown Levels:

  • Upper Bollinger Band: $25.08

Time-Sensitive Catalysts:

The upcoming earnings release on [Earnings Date] is a key catalyst to watch.

Risk Management:

A stop-loss level of $23.50 and position sizing considerations should be implemented to manage risk.

Overall, AVNS appears poised for a strong rebound, driven by its attractive valuation, improving technical trends, and positive news sentiment. While high volatility poses risks, the stock's beta suggests it may be less volatile than the broader market.

Generated
Earnings History
17 of 18 under expected move
Avg Expected Move
16.61%
Avg Actual Move
3.39%
Each row pairs the pre-earnings straddle-implied expected move with the realized close-to-close move. Sorted oldest first.
Earnings Date Timing Expected Move Actual Move Ratio Outcome
2021-02-18 After-Close 7.63% 1.75% 0.23x Within
2021-08-03 After-Close 1.87% 8.02% 4.29x Exceeded
2022-02-23 After-Close 14.07% 7.16% 0.51x Within
2022-05-04 After-Close 7.65% 4.20% 0.55x Within
2023-05-03 After-Close 22.05% 3.68% 0.17x Within
2023-08-09 After-Close 22.43% 0.64% 0.03x Within
2023-11-01 After-Close 10.73% 3.51% 0.33x Within
2024-01-04 After-Close 10.35% 0.06% 0.01x Within
2024-02-20 After-Close 7.85% 0.05% 0.01x Within
2024-05-02 After-Close 8.17% 0.15% 0.02x Within
2024-07-31 Pre-Market 13.83% 4.18% 0.30x Within
2024-10-30 After-Close 13.59% 0.54% 0.04x Within
2025-02-26 After-Close 8.48% 2.62% 0.31x Within
2025-05-06 After-Close 8.37% 2.10% 0.25x Within
2025-08-05 Pre-Market 54.89% 12.09% 0.22x Within
2025-11-05 After-Close 23.69% 4.88% 0.21x Within
2026-02-24 After-Close 23.28% 5.28% 0.23x Within
2026-05-05 After-Close 40.08% 0.08% 0.00x Within

Earnings calendar: this week’s reports with expected vs actual moves →

AVNS Options Activity & IV Rank

AVNS IV rank history, 52-week IV rank and IV percentile →

Volatility Metrics

Current IV: 8.4%
7-DTE IV: —
Expected Move: $20.00
7-DTE Move: $20.00
Days to Exp: 28 (2026-08-21)

Options Flow

Call Volume: 50
Put Volume: 500
P/C Volume: 10.0
BEARISH
Call OI: 63
Put OI: 504
P/C OI: 8.0
Total OI: 567

ATM Options Pricing

ATM Call: $10.00
ATM Put: $10.00
Call %: 40.0%
Put %: 40.0%

Chain Summary

Chain Volume: 756
Chain OI: 5,857
Last Updated: 7/24/2026
Spread Scanner GPU
Full Algorithm Docs ↗

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Dealer Positioning
HIGH γ vs HISTORY

Estimated net dealer gamma is at the 96th percentile of this name's own daily history, near the high end of its range. This describes current positioning; it is not a forecast or a trading signal.

Gamma percentile
96%
vs own history
GEX tilt
+0.63
OI-weighted, today
Vanna tilt
-0.45
δ-sensitivity to IV
Charm tilt
-0.78
δ-decay vs time
Vanna tilt -0.45: the estimated dealer exposure leans negative, so the modeled hedge would shift noticeably if implied volatility changed.
Charm tilt -0.78: the estimated dealer exposure leans negative, so the modeled hedge would shift noticeably as time passes and options approach expiry.

Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.

Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.

Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.

This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.

· 7 ATM contracts, 5k total OI
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d —
— pts EXTREME
as of Aug 10 · No data
30 DTE / 10d —
— pts EXTREME
as of Aug 10 · No data

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Enter a ticker to render the implied volatility surface.

Volatility Smile

Enter a ticker to render the implied volatility smile.

IV Rank (7 DTE)
IV Rank (30 DTE)1.5LowJul 24
Straddle Price (30 DTE)$20.00Jul 24
Beta Analysis
Insufficient price history — listed 4384 days ago. Beta and correlation vs SPY require ~1 year of daily returns to be statistically meaningful.
Notable investors who own AVNS
3 of 37 tracked investors
InvestorValueShare of their portfolioRankQ/Q sharesSource
Millennium Management Hedge fund
Izzy Englander
$37.9M
0.03%
#753 of 3716+10926.7%13F
Renaissance Technologies Hedge fund
Jim Simons
$6.4M
0.01%
#1316 of 3138new13F
Rockefeller Capital Management Family office
Rockefeller family
$1K
0.00%
#4564 of 47290.0%13F

Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions

AVNS Institutional Ownership (13F)

Latest filings — 2026-09-30
Diluted shares outstanding: 46,625,000 (as of 2026-03-31)

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

263 filers92,896,078 shares$2.21B value199.24% of float
# Filer Shares Value % of Total % of Float Period
1 BlackRock, Inc. Custodian 14,937,588 $371.65M 16.85% 32.04% 2026-06-30
2 NEXPOINT ASSET MANAGEMENT, L.P. 4,354,732 $108.35M 4.91% 9.34% 2026-06-30
3 State Street Corp 4,021,382 $100.05M 4.54% 8.62% 2026-06-30
4 Vanguard Capital Management LLC 3,987,588 $99.21M 4.50% 8.55% 2026-06-30
5 TIG Advisors, LLC 3,336,658 $83.02M 3.76% 7.16% 2026-06-30
6 Vanguard Group Inc Custodian 7,053,570 $79.21M 3.59% 15.13% 2025-12-31
7 Millennium Management LLC Custodian 3,049,106 $75.86M 3.44% 6.54% 2026-06-30
8 First Trust Capital Management L.P. 2,368,380 $58.93M 2.67% 5.08% 2026-06-30
9 Geode Capital Management, LLC Custodian 2,362,328 $58.79M 2.67% 5.07% 2026-06-30
10 JPMorgan Chase & Co Custodian 2,199,540 $54.83M 2.49% 4.72% 2026-06-30
11 Charles Schwab Investment Management, Inc. 1,892,688 $47.09M 2.14% 4.06% 2026-06-30
12 Vanguard Portfolio Management LLC 1,874,410 $46.64M 2.11% 4.02% 2026-06-30
13 AQR Arbitrage LLC 1,790,666 $44.55M 2.02% 3.84% 2026-06-30
14 FIL Ltd 1,630,000 $40.55M 1.84% 3.50% 2026-06-30
15 WATER ISLAND CAPITAL LLC 1,598,004 $39.76M 1.80% 3.43% 2026-06-30
16 Goldman Sachs Group Inc Custodian 1,530,832 $38.09M 1.73% 3.28% 2026-06-30
17 Polar Asset Management Partners Inc. 1,503,278 $37.40M 1.70% 3.22% 2026-06-30
18 Pentwater Capital Management LP 1,500,000 $37.32M 1.69% 3.22% 2026-06-30
19 Balyasny Asset Management L.P. 1,479,658 $36.81M 1.67% 3.17% 2026-06-30
20 Sand Grove Capital Management LLP 1,445,760 $35.97M 1.63% 3.10% 2026-06-30
21 Thrivent Financial for Lutherans 1,355,350 $33.72M 1.53% 2.91% 2026-06-30
22 Qube Research & Technologies Ltd 1,108,700 $27.58M 1.25% 2.38% 2026-06-30
23 Northern Trust Corp Custodian 1,046,140 $26.03M 1.18% 2.24% 2026-06-30
24 Morgan Stanley Custodian 945,288 $23.52M 1.07% 2.03% 2026-06-30
25 ALPINE ASSOCIATES MANAGEMENT INC. 865,242 $21.53M 0.98% 1.86% 2026-06-30
2 filers$15.79M notional
# Filer Notional Value % of Total Period
1 Susquehanna International Group, LLP Custodian $14.39M 91.12% 2026-06-30
2 Jane Street Group, LLC Custodian $1.40M 8.88% 2026-06-30
3 filers$6.13M notional
# Filer Notional Value % of Total Period
1 Susquehanna International Group, LLP Custodian $3.00M 48.94% 2026-06-30
2 Centiva Capital, LP $2.49M 40.58% 2026-06-30
3 CSS LLC/IL $641.90K 10.47% 2026-06-30

AVNS Insider Trading (Form 4)

Latest: 2026-07-28
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2026-07-28 Lisa Egbuonu-Davis Director Disp (D) −13,811 $25.00 -$345.3K EDGAR
2026-07-28 Patrick J Oleary Director Disp (D) −54,640 $25.00 -$1.37M EDGAR
2026-07-28 Indrani Lall Franchini Director Disp (D) −4,817 $25.00 -$120.4K EDGAR
2026-07-28 Sigfrido Delgado SVP, Operations Mixed −55,741 $25.00 -$2.77M EDGAR
2026-07-28 Scott Michael Galovan SVP, Chief Financial Officer Mixed −135,596 $25.00 -$5.79M EDGAR
2026-07-28 Julie Ann Shimer Director Disp (D) −50,090 $25.00 -$1.25M EDGAR
2026-07-28 Gary Blackford Director Disp (D) −119,590 $25.00 -$2.99M EDGAR
2026-07-28 David Pacitti Chief Executive Officer Mixed −322,194 $25.00 -$19.17M EDGAR
2026-05-12 Julie Ann Shimer Director Grant (A) +12,003 RSU — EDGAR
2026-05-12 Patrick J Oleary Director Grant (A) +12,003 RSU — EDGAR
2026-05-12 Lisa Egbuonu-Davis Director Grant (A) +12,003 RSU — EDGAR
2026-05-12 Indrani Lall Franchini Director Grant (A) +12,003 RSU — EDGAR
2026-05-12 Gary Blackford Director Grant (A) +12,003 RSU — EDGAR
2026-04-24 Sigfrido Delgado SVP, Operations Tax (F) −4,264 $24.64 -$105.1K EDGAR
2026-04-24 Scott Michael Galovan SVP, Chief Financial Officer Tax (F) −4,228 $24.64 -$104.2K EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.

AVNS Insider Holdings

6 insiders · @ $24.99
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 Joseph Fralin Woody Chief Executive Officer 402,776 $10.07M $291.6K 18 2025-03-10
2 Michael Greiner Former Interim CEO 204,493 $5.11M -$153.0K 18 2025-05-14
3 Mojirade James SVP, General Counsel 104,518 $2.61M $0 12 2025-04-24
4 Kerr Holbrook SVP, Chief Commercial Officer 85,026 $2.12M -$271.8K 12 2025-11-19
5 Sigfrido Delgado SVP, Operations 54,886 $1.37M $0 7 2026-07-28
6 John Joseph Hurley Principal Accounting Officer 13,592 $339.7K $0 17 2026-03-17
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.

AVNS Board & Officers

As of SEC filings through Jul 28, 2026

Officers 4

Changes in the last 10 years (35)
Jul 28, 2026Sigfrido Delgado reported in an SEC filing no longer being SVP, Operations
Jul 28, 2026Scott Michael Galovan reported in an SEC filing no longer being SVP, Chief Financial Officer
Jul 28, 2026Patrick J Oleary reported in an SEC filing no longer being a director
Jul 28, 2026Lisa Egbuonu-Davis reported in an SEC filing no longer being a director
Jul 28, 2026Julie Ann Shimer reported in an SEC filing no longer being a director
Jul 28, 2026Indrani Lall Franchini reported in an SEC filing no longer being a director
Jul 28, 2026Gary Blackford reported in an SEC filing no longer being a director
Jul 28, 2026David Pacitti reported in an SEC filing no longer being Chief Executive Officer
Aug 1, 2025Scott Michael Galovan became SVP, Chief Financial Officer
Apr 14, 2025The company announced the departure of Michael Greiner as Interim CEO in an SEC filing
Apr 14, 2025Jason Marc Pickett became Interim CFO and Treasurer
Apr 14, 2025David Pacitti became Chief Executive Officer
Mar 11, 2025Sigfrido Delgado listed as SVP, Operations (previously SVP, Integrated Supply Chain) in SEC filings
Oct 31, 2024Michael Greiner listed as Interim CEO (previously SVP - Chief Financial Officer) in SEC filings
Oct 28, 2024The company announced the departure of Joseph Fralin Woody from the board in an SEC filing
Oct 28, 2024The company announced the departure of Joseph Fralin Woody as Chief Executive Officer in an SEC filing
Jul 1, 2024Indrani Lall Franchini became a director
Jul 1, 2024Avanos Medical, Inc. became a director
May 13, 2024Sigfrido Delgado became SVP, Integrated Supply Chain
May 9, 2023Kerr Holbrook listed as SVP, Chief Commercial Officer (previously SVP, GM Chronic Care) in SEC filings
Not reported recently (16)
  • Warren J Machan · Last reported as SVP, Business Strategy in an SEC filing dated Nov 6, 2024
  • Avanos Medical, Inc. · Last reported as a director in an SEC filing dated Jul 3, 2024
  • Sudhakar Varshney · Last reported as SVP, Global Supply Chain in an SEC filing dated Mar 7, 2024
  • John P Byrnes · Last reported as a director in an SEC filing dated Jan 4, 2024
  • William David Haydon · Last reported as SVP, GM Pain Franchise in an SEC filing dated Mar 7, 2023
  • David Edward Ball · Last reported as SVP - Global Supply Chain in an SEC filing dated Sep 8, 2022
  • Renato Negro · Last reported as Vice President - Controller in an SEC filing dated May 7, 2021
  • Heidi Fields · Last reported as a director in an SEC filing dated Jan 6, 2021
  • William A Hawkins · Last reported as a director in an SEC filing dated Jan 6, 2021
  • John W Wesley · Last reported as SVP, General Counsel in an SEC filing dated May 11, 2020
  • Ronald W Dollens · Last reported as a director in an SEC filing dated Jan 8, 2020
  • John Raymond Tushar · Last reported as President, Global Franchises in an SEC filing dated May 10, 2019
  • Christopher M Lowery · Last reported as SVP, Chief Operating Officer in an SEC filing dated Nov 9, 2017
  • Rhonda D Gibby · Last reported as SVP, Human Resources in an SEC filing dated Nov 9, 2017
  • Robert E Abernathy · Last reported as President and CEO in an SEC filing dated May 5, 2017
  • Christopher G. Isenberg · Last reported as SVP, Global Supply Chain in an SEC filing dated May 5, 2017
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.

AVNS Proposed Insider Sales (Form 144)

Latest: 2025-11-18
Last 30d: 0 filings  ·  Last 90d: 0 filings

What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.

How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.

10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.

"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.

Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.

Filed Filer Role Shares Notice Value Planned Sale Broker Plan Link
2025-11-18 Holbrook Kerr Former Officer 15,000 $165.0K 2025-11-18 Fidelity Brokerage Services LLC — EDGAR
2025-03-06 Holbrook Kerr Officer 7,000 $106.8K 2025-03-06 Fidelity Brokerage Services LLC — EDGAR
2024-03-14 Greiner Michael Officer 8,000 $153.0K 2024-03-14 Fidelity Brokerage Services LLC — EDGAR
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed. Market-wide feed: Planned sales (Form 144).
ETF Holders
16 ETFs hold AVNS
16 shown · $36.17M total exposure
# ETF Provider Weight $ Exposure ETF AUM As Of
1 TSME Thrivent Small-Mid Cap Equity ETF Nport 1.39% $14.6M — 2026-06-30
2 FNDA Schwab Fundamental U.S. Small Company ETF Nport 0.10% $8.8M — 2026-05-31
3 SCHA Schwab U.S. Small-Cap ETF Nport 0.02% $5.5M — 2026-05-31
4 PSC Principal U.S. Small-Cap ETF Nport 0.07% $1.6M — 2026-06-30
5 TSCV Thrivent Small Cap Value ETF Nport 0.78% $1.5M — 2026-06-30
6 ARB AltShares Merger Arbitrage ETF Nport 1.21% $1.2M — 2026-05-31
7 EES WisdomTree U.S. SmallCap Fund Nport 0.13% $958,427 — 2026-06-30
8 SCHB Schwab U.S. Broad Market ETF Nport 0.00% $644,800 — 2026-05-31
9 OASC OneAscent Enhanced Small and Mid Cap ETF Nport 0.60% $503,192 — 2026-05-31
10 EVNT AltShares Event-Driven ETF Nport 2.02% $248,000 — 2026-05-31
11 OMFS Invesco Russell 2000 Dynamic Multifactor ETF Nport 0.07% $205,443 — 2026-05-31
12 QVMS Invesco S&P SmallCap 600 QVM Multi-Factor ETF Nport 0.08% $186,744 — 2026-05-31
13 FNDB Schwab Fundamental U.S. Broad Market ETF Nport 0.01% $100,787 — 2026-05-31
14 MSSM Morgan Stanley Pathway Small-Mid Cap Equity ETF Nport 0.01% $38,291 — 2026-05-31
15 ESIX State Street(R) SPDR(R) S&P SmallCap 600 ESG ETF Nport 0.07% $4,974 — 2026-03-31
16 RESM Columbia Research Enhanced Small Cap ETF Nport 0.05% $1,916 — 2026-06-30
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.

Trailing P/E
—
TTM Diluted EPS
$-1.60
TTM Revenue
$715.90M
TTM Net Income
$-74.40M
TTM Op. Cash Flow
$36.70M
Quarterly figures (12 quarters)
QuarterPeriod EndRevenueNet IncomeDiluted EPSOp. Cash Flow
Q1 '262026-03-31$182.20M$5.10M$0.11$-12.30M
Q4 '252025-12-31$180.90M$-1.30M$-0.02$28.20M
Q3 '252025-09-30$177.80M$-1.40M$-0.03$14.00M
Q2 '252025-06-30$175.00M$-76.80M$-1.66$6.80M
Q1 '252025-03-31$167.50M$6.60M$0.14$25.70M
Q4 '242024-12-31$179.60M$-397.30M$-8.64$57.90M
Q3 '242024-09-30$170.40M$4.30M$0.09$23.00M
Q2 '242024-06-30$171.70M$1.80M$0.04$27.80M
Q1 '242024-03-31$166.10M$-900.00K$-0.02$-8.00M
Q4 '232023-12-31$173.30M$10.50M$0.23$12.70M
Q3 '232023-09-30$171.30M$-3.70M$-0.08$29.10M
Q2 '232023-06-30$169.40M$-68.10M$-1.46$-2.60M
Q1 2026 • period ending 2026-03-31 • filed 2026-05-05
Valuation

Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.

Price Multiples
  • P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
  • P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
  • P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
  • EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
  • EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
Profitability & Yields
  • ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
  • ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
  • Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
  • FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
Balance Sheet
  • Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
  • Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
Reading the history chart
  • Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
  • Multiples expanding while earnings are flat = sentiment-driven rally.
  • Multiples compressing while earnings grow = value coming from fundamentals.
P/E
—
P/B
—
P/S
—
EV/EBITDA
—
EV/Sales
—
ROE
-9.5%
ROA
-7.1%
Div Yield
0.00%
FCF Yield
—
Debt/Equity
0.11
Current Ratio
—
Market Cap
$0.00
as of 2026-07-27
Short Interest & Float

Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.

Metric definitions
  • Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
  • SI % of Float — short interest / free float. The key crowding metric.
  • Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
  • Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
  • Free Float — shares available for public trading (total shares minus insider / restricted).
  • Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
  • SI % of Float < 5% — typical, no particular signal.
  • 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
  • 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
  • >30% — extreme; borrow is likely expensive and squeeze risk is material.
  • Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
  • Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
  • A sudden drop in SI after a rally may indicate a squeeze in progress.

Short interest is reported mid-month and end-of-month; short volume is daily.

Short Interest
1.75M
SI % of Float
3.95%
Days to Cover
2.35
Short Vol Ratio
74.3%
Free Float
44.34M
Float %
94.7%
Short interest 2026-07-15 • Short volume 2026-07-24 • Float 2026-06-05